SYNTHETIC PEPTIDE, SYNTHETIC LIPOPEPTIDE, IMMUNOGENIC CONJUGATE, VECTOR, DIAGNOSTIC REAGENT, METHOD OF INFECTION ASSAY, ANTIBODIES, METHOD OF OLIGOMER SYNTHESIS, SYNTHETIC VACCINE AGAINST HAEMOPHILUS INFLUENZAE, PROTECTED POLYSACCHARIDE

摘要

FIELD: molecular biology, biotechnology, genetic engineering. SUBSTANCE: synthetic peptide has amino acid sequence regarding at least to a single antigenic determinant at least a single protein, structural one, especially, P1, P2 and P6-proteins of Haemophilus influenzae (Hi), in part, B-type. Peptide is used as chimeric lipophilic form T-B bound with molecule-carrier, for example, synthetic PRP-molecule and/or polymerized product which is able to form molecular aggregates as vaccine against Hi. EFFECT: improved method of peptide synthesis.